BHVN Biohaven Pharmaceutical Holding Co

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.

$113.85  -1.70 (-1.47%)
As of 11/26/2021 13:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  British Virgin Islands
IPO date:  05/04/2017
Outstanding shares:  65,501,261
Average volume:  576,563
Market cap:   $7,568,670,709
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G11196105
ISIN:        VGG111961055
Sedol:      BZ8FXC4
Valuation   (See tab for details)
PE ratio:   -8.62
PB ratio:   54.50
PS ratio:   24.60
Return on equity:   147.14%
Net income %:   -281.25%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy